Jay Achar

14 ta ish

Federal State Budgetary Institution "Novosibirsk TB Research Institute"

1. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

   James M. Trauer, Jay Achar, Nargiza Parpieva +7

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyBMC Medicine20163 iqtibos

   ABIABI:AkademIndex/2026.other.195695

2. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan

   Shona Horter, Beverley Stringer, Nell Gray +5

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyBMC Infectious Diseases20203 iqtibos

   ABIABI:AkademIndex/2026.other.195708

3. Research Protocol - Effectiveness of a simplified short regimen for Multidrug Resistant Tuberculosis treatment in Karakalpakstan, Uzbekistan

   Philipp du Cros, Khamraev Atadjan, Mirzagalib Tillashaikhov +19

   Maqola20142 iqtibos

   ABIABI:AkademIndex/2026.other.363661

4. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan

   Johanna Kuhlin, Chris Smith, Atadjan Khaemraev +8

   MaqolaTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20181 iqtibos

   ABIABI:AkademIndex/2018.article.000181

5. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

   S.K. Abidi, Jay Achar, M.M. Assao Neino +34

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 iqtibos

   ABIABI:AkademIndex/2019.article.000020

6. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis

   Elizabeth Harausz, Anthony J. Garcia‐Prats, Stephanie J. Law +47

   Sharh maqolaOAOchiq kirish20181 iqtibos

   ABIABI:AkademIndex/2026.other.135315

7. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

   Philipp du Cros, Atadjan Khamraev, Zinaida Tigay +15

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyERJ Open Research20201 iqtibos

   ABIABI:AkademIndex/2026.other.360284

8. Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan

   Shona Horter, Jay Achar, Nell Gray +4

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyPLoS ONE20201 iqtibos

   ABIABI:AkademIndex/2026.other.360285

9. Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen

   Jay Achar, Catherine Berry, Krzysztof Herboczek +7

   BoshqaOAOchiq kirishTuberculosis Research and EpidemiologyEmerging infectious diseases20150 iqtibos

   ABIABI:AkademIndex/2015.other.000001

10. Accuracy of molecular drug susceptibility testing amongst tuberculosis patients in Karakalpakstan, Uzbekistan

    Horacio Gil, Hasmik Margaryan, I. Azamat +8

    MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyTropical Medicine & International Health20210 iqtibos

    ABIABI:AkademIndex/2021.article.003743

11. Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study

    Oleksandr Korotych, Jay Achar, Elmira Gurbanova +23

    MaqolaOAOchiq kirish20240 iqtibos

    ABIABI:AkademIndex/2024.article.018556

12. Effectiveness and Safety of Modified Fully Oral Nine-Month Treatment Regimens for Rifampicin-Resistant Tuberculosis: Prospective Cohort Study

    Oleksandr Korotych, Jay Achar, Elmira Gurbanova +23

    PreprintOAOchiq kirishTuberculosis Research and EpidemiologySSRN Electronic Journal20240 iqtibos

    ABIABI:AkademIndex/2024.preprint.000046

13. A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020

    Michael L. Rekart, Phone Thit, Modupe Oluya +14

    Sharh maqolaOAOchiq kirishTuberculosis Research and EpidemiologyIJTLD OPEN20240 iqtibos

    ABIABI:AkademIndex/2024.review-article.000146

14. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis

    Anthony J. Garcia‐Prats, Maria Garcia‐Cremades, Vivian Cox +97

    Sharh maqolaOAOchiq kirishTuberculosis Research and EpidemiologyThe Lancet Child & Adolescent Health20250 iqtibos

    ABIABI:AkademIndex/2025.review-article.000036